Market closed

iShares Nasdaq US Biotechnology/BTEC

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About BTEC ETF

The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index. The Index measures the performance of companies listed on the NASDAQ Stock Market that are classified as either biotechnology companies or pharmaceutical companies, according to their Industry Classification Benchmark (ICB) and that also meet other eligibility criteria as determined by NASDAQ, Inc. (the Index Provider), including minimum market capitalisation and liquidity requirements.

Ticker

BTEC

Fund name

iShares Nasdaq US Biotechnology

Trading on

LSE
Fund Manager
Share currency

Benchmark

NASDAQ Biotechnology TR

Base currency

USD

BTEC Metrics

$476M
Fund size
0.92
Beta

BTEC Fund Highlights

6.15%
5 year return
Accumulating
Use of income

0.35%

Annual fund charges

0.74%

Vs. other ETFs

0.07%

BTEC Fund Breakdown

Top holdingsSectorsCountries
Amgen

9.15%

Vertex Pharmaceuticals

8.86%

Regeneron Pharmaceuticals

8.31%

Gilead Sciences

7.30%

Moderna

5.69%

Astrazeneca Adr Rep 0.5

4.74%

Biogen

3.42%

Alnylam Pharmaceuticals

1.96%

Illumina

1.73%

Other

48.84%

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe

Buy BTEC

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events